Balkan Journal of Medical Genetics

A PILOT STUDY OF ANXA2, MED12, CALM1 AND MAPK1 GENE VARIANTS IN PRIMARY HYPERPARATHYROIDISM
Chorti A#1, Achilla C#2, Siasiaridis A2, Aristeidis I1, Cheva A3, Theodosios Papavramidis T##1, Chatzikyriakidou A##*2,4
*Corresponding Author: *Corresponding Author: Anthoula Chatzikyriakidou, Laboratory of Medical Biology - Genetics, Faculty of Medicine, School of Health Sciences, Aristotle University, 54124, Thessaloniki, Greece. Tel: +30 2310999013, Email: chatzikyra@auth.gr
page: 33

REFERENCES

1. Khundmiri SJ, Murray RD, Lederer E. PTH and vi- tamin D. Compr Physiol 2016;6:561– 601.size 2. Fraser WD. Hyperparathyroidism. The Lancet 2009;374:145–58. 3. Walker MD, Silverberg SJ. Primary hyperparathy- roidism. Nat Rev Endocrinol 2018;14:115–25. 4. Gopinath P, Mihai R. Hyperparathyroidism. Surgery 2011;29:451–8. 5. Mizamtsidi M, Nastos C, Mastorakos G, Dina R, Vassiliou I, Gazouli M, et al. Diagnosis, management, histology and genetics of sporadic primary hyperpar- athyroidism: Old knowledge with new tricks. Endocr Connect 2018;7:R56–68. 6. Li Z, Yu L, Hu B, Chen L, Jv M, Wang L, et al. Ad- vances in cancer treatment: a new therapeutic target, Annexin A2. J Cancer 2021;12:3587–96. 7. Ciregia F, Cetani F, Pardi E, Soggiu A, Piras C, Zal- locco L, et al. Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Com- parative Proteomic Analysis. Cancer Genomics Pro- teomics 2021;18:781–96. 8. Giusti L, Cetani F, Ciregia F, Da Valle Y, Donadio E, Giannaccini G, et al. A proteomic approach to study parathyroid glands. Mol Biosyst 2011;7:687–99. 9. Gonzalez C, Akula S, Burleson M. The role of media- tor subunit 12 in tumorigenesis and cancer therapeu- tics. Oncol Lett 2022;23:74. 10. Lim WK, Ong CK, Tan J, Thike AA, Ng CCY, Rajasegaran V, et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet 2014;46:877–80. 11. Chai YJ, Chae H, Kim K, Lee H, Choi S, Lee KE, et al. Comparative gene expression profiles in parathy- roid adenoma and normal parathyroid tissue. J Clin Med 2019;8. 12. Bhattacharya S, Bunick CG, Chazin WJ. Target selec- tivity in EF-hand calcium binding proteins. Biochim Biophys Acta 2004;1742:69–79. 13. Lu M, Berglund E, Larsson C, Höög A, Farnebo LO, Bränström R. Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in hu- man parathyroid adenoma. Journal of Endocrinology 2011;208:31–9. 14. Guo Y, Pan W, Liu S, Shen Z, Xu Y, Hu L. ERK/ MAPK signalling pathway and tumorigenesis. Exp Ther Med 2020;19:1997–2007. 15. Mahalingam CD, Datta T, Patil R V., Kreider J, Bonfil RD, Kirkwood KL, et al. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone. Journal of Endocrinology 2011;211:145–56. 16. Van Der Walt J. Pathology of the parathyroid glands. Diagnostic Histopathology 18(6): 2012. 17. Viechtbauer W, Smits L, Kotz D, Budé L, Spigt M, Serroyen J, et al. A simple formula for the calcula- tion of sample size in pilot studies. J Clin Epidemiol 2015;68:1375–9. 18. Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res 2016;25:1057–73. 19. Mazeh H, Sippel RS, Chen H. The role of gender in primary hyperparathyroidism: same disease, different presentation. Ann Surg Oncol. 2012;19:2958-62. 20. Wang H, Shen Q, Ye L hua, Ye J. MED12 mutations in human diseases. Protein Cell 2013;4:643–6. 21. Fairoozy RH, Cooper J, White J, Giambartolomei C, Folkersen L, Wannamethee SG, et al. Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene. Atherosclerosis 2017;261:60–8. 22. Pereira-Martins DA, Coelho-Silva JL, Domingos IF, Weinhäuser I, Silveira DR, Cunha AF, et al. Associa- tion between ANXA2*5681 variant (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients. Br J Haematol2020;188:e8–11. 23. Pandey S, Ranjan R, Pandey S, Mishra RM, Seth T, Saxena R. Effect of ANXA2 gene single nucleotide variant (SNP) on the development of osteonecrosis in Indian sickle cell patient: A PCR-RFLP approach. Indian J Exp Biol 2012;50:455–8. 24. Chang MT, Asthana S, Gao SP, Lee BH, Chapman JS, Kandoth C, et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mu- tational specificity. Nat Biotechnol 2016;34:155–63. 25. Mototani H, Mabuchi A, Saito S, Fujioka M, Iida A, Takatori Y, et al. A functional single nucleotide variant in the core promoter region of CALM1 is associated with hip osteoarthritis in Japanese. Hum Mol Genet 2005;14:1009–17. 26. Yang H, Hu Z, Zhuang C, Liu R, Zhang Y. Association between the variants of CALM1 gene and osteoar- thritis risk: A meta-analysis based on observational studies. Biosci Rep 2018;38. 27. Shi J, Gao ST, Lv ZT, Sheng W Bin, Kang H. The as- sociation between rs12885713 variant in CALM1 and risk of osteoarthritis: A meta-analysis of case–control studies. Medicine 2018;97. 28. Zhao D, Qiu GX, Wang YP, Zhang JG, Shen JX, Wu ZH, et al. Association of calmodulin1 gene variants with susceptibility to adolescent idiopathic scoliosis. Orthop Surg 2009;1:58–65. 29. Zhao D, Qiu GX, Wang YP, Zhang JG, Shen JX, Wu ZH. Association between adolescent idiopathic scoliosis with double curve and variants of calmo- dulin1 gene/estrogen receptor-α gene. Orthop Surg 2009;1:222–30. 30. Cheva A, Chorti A, Boulogeorgou K, Chatzikyri- akidou A, Achilla C, Bontinis V, Bontinis A, Milias S, Zarampoukas T, Bakkar SY, Papavramidis T. Sporadic Parathyroid Adenoma: A Pilot Study of Novel Biomarkers in Females. Medicina (Kaunas). 2024;60:1100. 31. Leon AC, Davis LL, Kraemer HC. The role and interpretation of pilot studies in clinical research. J Psychiatr Res. 2011;45:626-9. 32. Kunselman AR. A brief overview of pilot studies and their sample size justification. Fertil Steril. 2024 Jun;121(6):899-901 33. Brewer K, Costa-Guda J, Arnold A. Molecular genetic insights into sporadic primary hyperparathyroidism. Endocr Relat Cancer 2019;26:R53–72. 34. Hunter D, De Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker R V., et al. Genetic contri- bution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation. Jour- nal of Bone and Mineral Research 2001;16:371– 8. 35. Wang XM, Wu YW, Li ZJ, Zhao XH, Lv SM, Wang XH. Variants of CASR gene increase the risk of primary hyperparathyroidism. J Endocrinol Invest 2016;39:617–25. 36. Soto-Pedre E, Newey PJ, Srinivasan S, Siddiqui MK, Palmer CNA, Leese GP. Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT. Journal of Clinical Endocrinology and Metabolism 2022;107:3302–8. 37. Correa P, Lundgren E, Rastad J, Åkerström G, Westin G, Carling T. Multiple endocrine neoplasia type 1 variant D418D is associated with sporadic primary hyperparathyroidism. Surgery 2002;132:450–5. 38. Chorti A, Achilla C, Tsalkatidou D, Moysidis M, Cheva A, Chatzikyriakidou A, et al. A Pilot Study of the Association VDR Variants With Primary Hyper- parathyroidism. In Vivo 2023;37:1111–6. 39. Colhoun HM, McKeigue PM, Smith GD. Problems of reporting genetic associations with complex out- comes. Lancet 2003;361:865–72. 40. Munafò MR, Attwood AS, Flint J. Letter to the editor: Bias in genetic association studies: Effects of research location and resources. Psychol Med 2008;38:1213–4. 41. Bias in Reporting of Genetic Association Studies. PLoS Med 2005;2:e419. 42. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genetics in Medicine 2002;4:46–61. 43. Kraft P, Zeggini E, Ioannidis JPA. Replication in genome-wide association studies. Statistical Science 2009;24:561–73. 44. Tam V, Patel N, Turcotte M, Bossé Y, Paré G, Meyre D. Benefits and limitations of genome-wide associa- tion studies. Nat Rev Genet2019;20:467–84. 45. van Teijlingen E, Hundley V. The importance of pilot studies. Nurs Stand. 2002 Jun 19-25;16:33.

Number 27 VOL. 27 (2), 2024	Number 27 VOL. 27 (1), 2024
Number 26 Number 26 VOL. 26(2), 2023 All in one	Number 26 VOL. 26(2), 2023
Number 26 VOL. 26, 2023 Supplement	Number 26 VOL. 26(1), 2023
Number 25 VOL. 25(2), 2022	Number 25 VOL. 25 (1), 2022
Number 24 VOL. 24(2), 2021	Number 24 VOL. 24(1), 2021
Number 23 VOL. 23(2), 2020	Number 22 VOL. 22(2), 2019
Number 22 VOL. 22(1), 2019	Number 22 VOL. 22, 2019 Supplement
Number 21 VOL. 21(2), 2018	Number 21 VOL. 21 (1), 2018
Number 21 VOL. 21, 2018 Supplement	Number 20 VOL. 20 (2), 2017
Number 20 VOL. 20 (1), 2017	Number 19 VOL. 19 (2), 2016
Number 19 VOL. 19 (1), 2016	Number 18 VOL. 18 (2), 2015
Number 18 VOL. 18 (1), 2015	Number 17 VOL. 17 (2), 2014
Number 17 VOL. 17 (1), 2014	Number 16 VOL. 16 (2), 2013
Number 16 VOL. 16 (1), 2013	Number 15 VOL. 15 (2), 2012
Number 15 VOL. 15, 2012 Supplement	Number 15 Vol. 15 (1), 2012
Number 14 14 - Vol. 14 (2), 2011	Number 14 The 9th Balkan Congress of Medical Genetics
Number 14 14 - Vol. 14 (1), 2011	Number 13 Vol. 13 (2), 2010
Number 13 Vol.13 (1), 2010	Number 12 Vol.12 (2), 2009
Number 12 Vol.12 (1), 2009	Number 11 Vol.11 (2),2008
Number 11 Vol.11 (1),2008	Number 10 Vol.10 (2), 2007
Number 10 10 (1),2007	Number 9 1&2, 2006
Number 9 3&4, 2006	Number 8 1&2, 2005
Number 8 3&4, 2004	Number 7 1&2, 2004
Number 6 3&4, 2003	Number 6 1&2, 2003
Number 5 3&4, 2002	Number 5 1&2, 2002
Number 4 Vol.3 (4), 2000	Number 4 Vol.2 (4), 1999
Number 4 Vol.1 (4), 1998	Number 4 3&4, 2001
Number 4 1&2, 2001	Number 3 Vol.3 (3), 2000
Number 3 Vol.2 (3), 1999	Number 3 Vol.1 (3), 1998
Number 2 Vol.3(2), 2000	Number 2 Vol.1 (2), 1998
Number 2 Vol.2 (2), 1999	Number 1 Vol.3 (1), 2000
Number 1 Vol.2 (1), 1999	Number 1 Vol.1 (1), 1998

About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact